Navigation Links
Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations
Date:9/23/2008

Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately.

Rye, NY (PRWEB) September 23, 2008 -- Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately. Dr. Zinberg will be responsible for the day-to-day management of Curemark as well as for the implementation of Curemark’s strategic plan.

“In addition to having an outstanding track record in the health care field, Dr. Zinberg brings a tremendous level of expertise, energy and business acumen to Curemark,” states Dr. Joan Fallon, Curemark’s CEO. “We are honored to have someone of Dr. Zinberg’s caliber as Curemark’s new Vice–President of Operations.”

Dr. Zinberg was previously the Chief Operating Officer of a privately held multi-million dollar health care corporation, The Masters Circle. The Masters Circle provides consulting services to the health care sector within the United States and internationally.

“As Curemark is preparing to enter clinical trials for its proprietary drug for autism, Dr. Zinberg joins us at a most historic time,” states Dr. Matthew Heil, Vice-President for Drug Development and Manufacturing for Curemark. “She will help lead us into the next phases of our company development, and implementation of our strategic plan for our vast array of clinical targets.”

Curemark is a biotechnology company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company’s initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon. The company is currently preparing for clinical trials. To learn more about our innovative science, please visit: www.cure-mark.com.

Media Contact:
Alissa Minio
info @ cure-mark.com
(914) 925-3450

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1366754.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
2. US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer
3. Wolters Kluwer Health Appoints Scott Lubeck Vice President, Technology of its Professional & Education Unit
4. Millennium Pharmacy Systems, Inc. Appoints New CEO
5. National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry:
6. U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board
7. Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board
8. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
9. Cadient Group Appoints Andrew le Blanc as Creative Director
10. Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
11. Sonic Innovations Appoints New President and COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... today that nominations will be accepted February 8, 2016 through May 8, ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with ... time to make a change in public health,” states Carole Baggerly, Director of ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now ... country. The AutismOne 2016 Conference, which is being held May 25-29 at the Loews ... elsewhere about helpful interventions and causes of chronic illness in children. , Very recent ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... Pekin, IL (PRWEB) , ... February 06, 2016 ... ... the recovery phases of eating disorder treatment helps to reduce the frequency and ... “Tasks of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - ... Medical Devices sector report, "Aesthetic Devices - Medical Devices ... currently in pipeline stage. This report ... and primary research by GlobalData,s team of industry experts. ... removed or altered based on the availability and relevance ...
(Date:2/8/2016)... SAN DIEGO , Feb. 8, 2016  Neurocrine ... the Company will report its fourth quarter and year-end ...  February 11, 2016.  Neurocrine will then host a live ... and provide a Company update Thursday afternoon, February 11, ... Time). http://www.neurocrine.com . --> http://www.neurocrine.com ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016   GS1 ... healthcare professionals to guide them through GS1 Standards implementation ... Drug Administration (FDA) Unique Device Identification (UDI) rule. ... GS1 US; Beth Gibson , senior director industry ... , industry development director, GS1 US --> ...
Breaking Medicine Technology: